Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May;599(10):1468-1480.
doi: 10.1002/1873-3468.15106. Epub 2025 Jan 28.

Ablation of LRP6 in alpha-smooth muscle actin-expressing cells abrogates lung inflammation and fibrosis upon bleomycin-induced lung injury

Affiliations

Ablation of LRP6 in alpha-smooth muscle actin-expressing cells abrogates lung inflammation and fibrosis upon bleomycin-induced lung injury

Eun-Ah Sung et al. FEBS Lett. 2025 May.

Abstract

Tissue fibrosis is a progressive pathological process with excessive deposition of extracellular matrix proteins (ECM). Myofibroblasts, identified by alpha-smooth muscle actin (αSMA) expression, play an important role in tissue fibrosis by producing ECM. Here, we found that the Wnt antagonist Dickkopf1 (DKK1) induced gene expressions associated with inflammation and fibrosis in lung fibroblasts. We demonstrated that genetic deletion of LRP6, a receptor for Wnt ligands and DKK1, in αSMA-expressing cells using Acta2-cre Lrp6fl/fl (Lrp6AKO) mice abrogated the bleomycin (BLM)-induced lung inflammation and fibrosis phenotype, suggesting an important role for LRP6 in modulating inflammation and fibrotic processes in the lung. Our results highlight the crucial role of LRP6 in fibroblasts in regulating inflammation and fibrosis upon BLM-induced lung injury.

Keywords: LRP6; fibrosis; inflammation.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
DKK1 induces gene expressions for inflammation and tissue repair in lung fibroblasts. (A–C) Lung fibroblasts were treated with DKK1 for 24 h prior to bulk RNA seq. KEGG pathway enrichment analysis (A) and Gene Ontology (GO) enrichment analysis (B) were conducted to identify significantly upregulated pathways in DKK1‐treated group compared to untreated group. DEG analysis between untreated and DKK1‐treated group is visualized in the form of a heatmap (C).
Fig. 2
Fig. 2
Lrp6 AKO mice showed normal hematological phenotypes. (A) LRP6 expressions in αSMA+ or αSMA populations were quantified by flow cytometry from the lungs of Lrp6 AKO and Lrp6 fl/fl mice. (B) Inflammatory cells in the peripheral blood from Acta2cre‐Lrp6 fl/fl and Lrp6 fl/fl mice were analyzed by Hemavet. Shown are white blood cells (WBC), lymphocytes, monocytes, neutrophils, eosinophils, basophils, red blood cells (RBC), platelets, and mean corpuscular volume (MCV) (n = 5). Data are presented as the mean ± SD. Student's t‐test. ns, not significant.
Fig. 3
Fig. 3
Lrp6 AKO mice showed reduced BLM‐induced lung fibrosis phenotypes. (A–E) Lrp6 AKO and their littermate controls Lrp6 fl/fl mice were challenged with BLM on day 0. Two weeks later, the lungs were harvested. (A) Representative images of Masson staining are shown. Scale bar = 800 μm (top), 100 μm (bottom). (B) Hydroxyproline concentration was measured (n = 5). (C) αSMA protein levels were analyzed by IHC and imagej (n = 5). (D) Representative images of IHC are shown. Scale bar = 100 μm. (E) The ratio of αSMA, DKK1 and IL‐11 to Gapdh was quantified by western blot and imagej (n = 3). Data are represented as means ± SD. One‐way ANOVA with Tukey's post hoc test. ***P < 0.001, **P < 0.005, *P < 0.05, ns, not significant.
Fig. 4
Fig. 4
Lrp6 AKO mice showed reduced BLM‐induced lung inflammation. (A, B) Lrp6 AKO and their littermate controls Lrp6 fl/fl mice were challenged with BLM. Two weeks later, the lungs were harvested. (A) Representative images of H&E staining are shown. Scale bar = 800 μm (top), 100 μm (bottom). (B) CD45+ leukocytes, macrophages, neutrophils, CD4+ T cells, CD8+ T cells and Treg cells were quantitated by flow cytometry. Data are represented as means ± SD (n = 4 or 6). One‐way ANOVA with Tukey's post hoc test. ***P < 0.001, **P < 0.005, *P < 0.05, ns, not significant.

Update of

Similar articles

References

    1. Mack M (2018) Inflammation and fibrosis. Matrix Biol 68–69, 106–121. - PubMed
    1. Wynn TA (2011) Integrating mechanisms of pulmonary fibrosis. J Exp Med 208, 1339–1350. - PMC - PubMed
    1. Nusse R and Clevers H (2017) Wnt/β‐catenin signaling, disease, and emerging therapeutic modalities. Cell 169, 985–999. - PubMed
    1. Bourhis E, Tam C, Franke Y, Bazan JF, Ernst J, Hwang J, Costa M, Cochran AG and Hannoush RN (2010) Reconstitution of a frizzled8.Wnt3a.LRP6 signaling complex reveals multiple Wnt and Dkk1 binding sites on LRP6. J Biol Chem 285, 9172–9179. - PMC - PubMed
    1. Chen S, Bubeck D, MacDonald BT, Liang WX, Mao JH, Malinauskas T, Llorca O, Aricescu AR, Siebold C, He X et al. (2011) Structural and functional studies of LRP6 ectodomain reveal a platform for Wnt signaling. Dev Cell 21, 848–861. - PMC - PubMed

MeSH terms

Substances